Sipavibart for preventing COVID-19 [ID6282]

Final scope (PDF 242 KB)

Final stakeholder list (PDF 206 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 1.26 MB)

Final scope (PDF 243 KB)

Final stakeholder list (PDF 204 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 1.26 MB)

Draft matrix post referral (PDF 177 KB)